Cargando…
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
OBJECTIVE: Recent studies have found aristaless-related homeobox gene (ARX)/pancreatic and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked (ATRX)/death domain-associated protein (DAXX) and alternative lengthening of telomeres (ALT) to be promising prognostic biomarkers for...
Ejemplares similares
-
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine‐needle aspiration
por: Hackeng, Wenzel M., et al.
Publicado: (2019) -
Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures
por: Singhi, Aatur D, et al.
Publicado: (2020) -
Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis
por: Kaçmaz, Enes, et al.
Publicado: (2019) -
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
por: Hackeng, Wenzel M., et al.
Publicado: (2020) -
KRAS Amplification in Metastatic Colon Cancer is
Associated with a History of Inflammatory Bowel Disease and May Confer
Resistance to anti-EGFR Therapy
por: Favazza, Laura A., et al.
Publicado: (2020)